| [1] |
Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.
Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer
[J]. Journal of International Oncology, 2024, 51(6): 321-325.
|
| [2] |
Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.
Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study
[J]. Journal of International Oncology, 2024, 51(6): 326-331.
|
| [3] |
Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.
Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer
[J]. Journal of International Oncology, 2024, 51(6): 332-337.
|
| [4] |
Yuan Jian, Huang Yanhua.
Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer
[J]. Journal of International Oncology, 2024, 51(6): 338-343.
|
| [5] |
Chen Hongjian, Zhang Suqing.
Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients
[J]. Journal of International Oncology, 2024, 51(6): 344-349.
|
| [6] |
Zhang Baihong, Yue Hongyun.
Advances in anti-tumor drugs with new mechanisms of action
[J]. Journal of International Oncology, 2024, 51(6): 354-358.
|
| [7] |
Xu Fenglin, Wu Gang.
Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2024, 51(6): 359-363.
|
| [8] |
Wang Ying, Liu Nan, Guo Bing.
Advances of antibody-drug conjugate in the therapy of metastatic breast cancer
[J]. Journal of International Oncology, 2024, 51(6): 364-369.
|
| [9] |
Gao Fan, Wang Ping, Du Chao, Chu Yanliu.
Research progress on intestinal flora and non-surgical treatment of the colorectal cancer
[J]. Journal of International Oncology, 2024, 51(6): 376-381.
|
| [10] |
Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.
Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy
[J]. Journal of International Oncology, 2024, 51(5): 257-266.
|
| [11] |
Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.
Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer
[J]. Journal of International Oncology, 2024, 51(5): 286-291.
|
| [12] |
Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng.
Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor
[J]. Journal of International Oncology, 2024, 51(5): 298-302.
|
| [13] |
Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan.
Progress of ferroptosis-related mechanisms in osteosarcoma
[J]. Journal of International Oncology, 2024, 51(5): 308-311.
|
| [14] |
Yang Hao, Shi Guidong, Zhang Chengcheng, Zhang Yue, Zhang Liwen, Fu Maoyong.
Comparison of efficacy and safety between sintilimab and tislelizumab in neoadjuvant therapy for advanced esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2024, 51(4): 210-216.
|
| [15] |
Sa Qiang, Xu Hangcheng, Wang Jiayu.
Advances in immunotherapy for breast cancer
[J]. Journal of International Oncology, 2024, 51(4): 227-234.
|
